REPORT HIGHLIGHT
In-vitro Toxicology Testing market was valued at USD 8.23 billion by 2019, growing with 9.1% CAGR during the forecast period, 2020-2026
Market Dynamics
The rise in the number of research & development activities for in-vitro testing, growing awareness regarding the environmental concerns, and ban on animal testing are the major factors driving the growth of global in-vitro toxicology testing market. In addition, increasing ethical concerns related to animal testing procedures coupled with efforts taken by various animal welfare organizations are paving way for the reduction or replacement of animal testing with in-vitro toxicology testing. For example, the U.S. EPA (Environmental Protection Agency) presented a draft policy in 2018 that proposes the usage of in vitro methods to minimalize the use of animal in testing chemicals that cause skin sensitization or inflammation.
Furthermore, the emergence of novel approaches of 3D cell culture and advancements in genetic screening and genetics approaches are likely to create lucrative opportunities in the overall market during the forecast period. Conversely, the predictive ability of in-vitro testing as compared to vivo testing and insufficient in-vitro models to determine autoimmunity & immune-stimulation is predicted to hamper the market growth in the coming future.
Regional Takeaways
Presently, Europe region is playing a dominant role in the global market for in-vitro toxicology testing owing to the technological advancements, increasing consciousness related to the significance of a healthy lifestyle, and growing geriatric population in the region.
The Asia-Pacific market for in-vitro toxicology testing is anticipated to witness the fastest growth rate during the period of forecast. The rapid growth of this region is majorly due to the rising focus of government organizations to encourage in-vitro methods’ toxicology testing. Additionally, the clinical trials conducted in Asian countries is cost-effective as compared to western countries.
Further key findings of the study include:
• The cell culture technology segment subjugated the market in 2019 and is projected to continue its dominance throughout the forecast. This is majorly because the cell culture serves as an excellent model for exploration of toxic effects by providing consistent samples as well as reproducible results. This allows early-stage finding of toxicity in the drug development procedure.
• The cellular assay method accounted for the majority of market share in 2019 and is expected to grow at a healthy CAGR during the forecast period. This growth is majorly because of the availability of cellular assay at a broader level for pharmacokinetic reporting of drug products. Besides, several biotechnological and pharmaceutical companies are essentially reliant on cellular assays for early stages of drug development in toxicity screening.
• The systemic toxicology held the largest market share in terms of revenue in 2019 and is projected to subjugate the global in-vitro toxicology testing market during the forecast period. This is attributed to the development of multiple organ plate coupled with simulated blood flow for measuring systemic toxicity.
• The usage of IVTT is highest in the pharmaceutical industry primarily owing to the increase in demand for biopharmaceuticals and the wider usage of toxicology testing mainly in the pharmacokinetic analysis of the generic, novel, and modified pharmaceutical products.
• Key market players operating in the industry include Merck KGaA, Bio-Rad Laboratories, Inc., Charles River, Abbott, Catalent, Inc., Thermo Fisher Scientific Inc., GE Healthcare, Eurofins Scientific, Quest Diagnostics Incorporated, Evotec, and Laboratory Corporation of America Holdings.
The market size and forecast for each segment and sub-segments has been considered as below:
• Historical Year – 2015 to 2018
• Base Year – 2019
• Estimated Year – 2020
• Projected Year – 2026
TARGET AUDIENCE
? Traders, Distributors, and Suppliers
? Manufacturers
? Government and Regional Agencies
? Research Organizations
? Consultants
? Distributors
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY
? Cell Culture Technology
? High Throughput Technology
? Molecular Imaging
? OMICS Technology
GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD
? Cellular Assay
? Ex-vivo
? Biochemical Assay
? In Silico
? Others
GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET, BY APPLICATION
? Dermal Toxicity
? Endocrine Disruption
? Systemic Toxicology
? Ocular Toxicity
? Others
GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET, BY END USE
? Food Industry
? Pharmaceutical Industry
? Chemicals Industry
? Cosmetics & Household Products
? Diagnostics
? Others
GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET, BY REGION
? North America
o The U.S.
o Canada
? Europe
o Germany
o France
o Italy
o Spain
o United Kingdom
o Rest of Europe
? Asia Pacific
o India
o China
o South Korea
o Japan
o Singapore
o Rest of APAC
? Latin America
o Brazil
o Mexico
o Argentina
o Rest of LATAM
? Middle East and Africa
o Saudi Arabia
o United Arab Emirates
o Rest of MEA